| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/14/2011 | CN101210012B Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 09/14/2011 | CN101163696B Histone deacetylase inhibitors |
| 09/14/2011 | CN101111505B 伊班膦酸盐多晶型物b Ibandronate polymorph b |
| 09/13/2011 | USRE42700 Induction of apoptosis in cancer cells |
| 09/13/2011 | US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017725 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017640 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017607 N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions |
| 09/13/2011 | US8017599 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017587 2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 09/13/2011 | US8017585 CXCR4 antagonist and use thereof |
| 09/13/2011 | US8017584 Tumor associated antigens; fusion proteins; antibodies; keyhole limpet hemocyanin carrier enhances immunogenicity |
| 09/13/2011 | US8017581 MSH-agonist tripeptide conjugates |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | CA2628857C Formulation and method for treating neoplasms by inhalation |
| 09/13/2011 | CA2528096C Cis-imidazolines as mdm2 inhibitors |
| 09/13/2011 | CA2525873C Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/13/2011 | CA2518964C Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/13/2011 | CA2493614C Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2465303C Compositions and methods for wt1 specific immunotherapy |
| 09/13/2011 | CA2448251C Metal complexes and therapeutic uses thereof |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/13/2011 | CA2430070C A process for the preparation of taxan derivatives |
| 09/13/2011 | CA2407573C Imidazopyridine derivatives |
| 09/13/2011 | CA2378187C Methods for treating therapy-resistant tumors |
| 09/13/2011 | CA2351735C Engineered cytotoxic ribonuclease |
| 09/13/2011 | CA2334119C Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 09/13/2011 | CA2271690C Methods for regulating angiogenesis |
| 09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
| 09/12/2011 | CA2697887A1 Modulating and/or detecting activation induced deaminase and methods of use thereof |
| 09/09/2011 | WO2011109593A1 Substituted-5-aminopyrrolo/pyrazolopyridines |
| 09/09/2011 | WO2011109422A2 Compositions and methods for the treatment of cancer |
| 09/09/2011 | WO2011109387A1 Radiotherapy combined with hypoxic cell sensitizers |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011109012A1 Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108930A1 A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
| 09/09/2011 | WO2011108796A1 Composition for preventing or treating cancer, containing letm1 |
| 09/09/2011 | WO2011108699A1 Gene related to the action of isoflavones |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011108499A1 Osteoblast differentiation promoter, pharmaceutical composition for promoting ossification, and health food containing auraptene analog as active ingredient |
| 09/09/2011 | WO2011108000A1 Isolation of a natural lead with potential of p38 mitogen activated protein kinase and c-jun-n terminal kinase inhibiting activity |
| 09/09/2011 | WO2011107870A2 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 09/09/2011 | WO2011107709A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 09/09/2011 | WO2011107648A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011107647A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011107586A1 Smoc1, tenascin-c and brain cancers |
| 09/09/2011 | WO2011107553A1 Antibodies against human csf-1r and uses thereof |
| 09/09/2011 | WO2011107437A1 Microvesicles (mvs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease |
| 09/09/2011 | WO2011107100A1 Methods and compositions for regulation of herv4 |
| 09/09/2011 | WO2011106997A1 Novel 10-23 deoxyribozyme analogues and uses thereof |
| 09/09/2011 | WO2011106981A1 Use of cytokine-superantigen fusion protein for preparing medicament against solid tumor |
| 09/09/2011 | WO2011106839A1 Skin cancer prevention and treatment |
| 09/09/2011 | WO2011083091A3 Methods for treating pancreatic cancer |
| 09/09/2011 | WO2011076711A3 Polymorphs of salts of 4- [4- [ [4-chloro-3- (trifluoromethyl) phenyl] carbamoylamino] phenoxy] -n-methylpyridine - 2 - carboxamide |
| 09/09/2011 | WO2011064559A3 Novel inositol phosphate derivatives |
| 09/09/2011 | WO2011060409A3 Cullen 5 as a regulator of hsp90 clients : a new target for drug development |
| 09/09/2011 | WO2011060253A3 Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms |
| 09/09/2011 | WO2011058027A3 N-9-substituted purine compounds, compositions and methods of use |
| 09/09/2011 | CA2828833A1 Pharmaceutical compositions comprising monoterpenes |
| 09/09/2011 | CA2795698A1 Modulation of intracellular signaling |
| 09/09/2011 | CA2791990A1 Radiotherapy combined with hypoxic cell sensitizers |
| 09/09/2011 | CA2791914A1 Nuclear transport modulators and uses thereof |
| 09/09/2011 | CA2791897A1 Sandalwood oil and its uses |
| 09/09/2011 | CA2791738A1 Compounds for treatment of cancer |
| 09/09/2011 | CA2791680A1 Compounds and therapeutic uses thereof |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791490A1 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 09/09/2011 | CA2791457A1 Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| 09/09/2011 | CA2791383A1 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 09/09/2011 | CA2790707A1 Fluorouracil derivatives |
| 09/09/2011 | CA2789076A1 Antibodies against human csf-1r and uses thereof |
| 09/08/2011 | US20110219464 Lung disease targets and uses thereof |
| 09/08/2011 | US20110218333 Internalizing ErbB2 antibodies |
| 09/08/2011 | US20110218231 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases |
| 09/08/2011 | US20110218230 Natriuretic peptide related fragment in cardiovascular disease |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
| 09/08/2011 | US20110218212 Predictive markers for egfr inhibitors treatment |
| 09/08/2011 | US20110218211 Azaindole inhibitors of iap |
| 09/08/2011 | US20110218210 Compounds for treating abnormal cellular proliferation |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/08/2011 | US20110218199 Pyridoneamide derivatives, their manufacture and use as pharmaceutical agents |
| 09/08/2011 | US20110218198 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 09/08/2011 | US20110218193 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 09/08/2011 | US20110218187 Inhibitors of tyrosine kinases |
| 09/08/2011 | US20110218184 Quinolone analogs and methods related thereto |
| 09/08/2011 | US20110218183 Fused Bicyclic mTOR Inhibitors |